. . . . . . . . . . . . . . . . . . . . . . . "TextLocation" . "Review" . "a(SCHEM:\"ML 9\") -| (p(HGNC:INS) -> tloc(p(HGNC:SLC2A4),MESHCL:\"Intracellular Space\",MESHCL:\"Cell Membrane\"))" . "p(HGNC:INS) -> tloc(p(HGNC:SLC2A4),MESHCL:\"Intracellular Space\",MESHCL:\"Cell Membrane\")" . "Approximately 2000 hand curated statements drawn from 57 PubMeds." . "Copyright (c) 2011-2012, Selventa. All Rights Reserved." . "BEL Framework Small Corpus Document" . "Creative Commons Attribution-Non-Commercial-ShareAlike 3.0 Unported License" . . "1.6" . "Conversely, the use of 1-(5-Chloronaphthalene-1-sulfonyl) homopiperazine (ML-9) compound\n(Fig. 5) as an inhibitor of PKB/Akt enzymatic activity (IC50=10-50 mM) [50]\nhas revealed that activation of PKB/Akt is necessary for the acute (GLUT4 translocation)\nand chronic (GLUT4 gene expression) insulin effects that lead to glucose\nuptake [51]" . . "support@belframework.org" . "Selventa" . . . . "2014-07-03T14:29:32.533+02:00"^^ . . .